Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06700915 · ClinicalTrials.gov registry record · NA
A Clinical Trial to Assess the Efficacy and Tolerance of a Berberine-based Nutraceutical Formula to Aid Blood Sugar Regulation and Metabolism
A NA study of Metabolism Disorder and Nutraceutical, sponsored by Ultimate International.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06700915: Recruiting NA study of Metabolism Disorder and Nutraceutical, sponsored by Ultimate International.
NCT06700915 is a NA study of Metabolism Disorder and Nutraceutical that is actively recruiting participants, run by Ultimate International. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06700915, a NA study of Metabolism Disorder and Nutraceutical, is actively recruiting participants, sponsored by Ultimate International.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized, triple-blind, placebo-controlled study will evaluate the efficacy of Diaberine, a berberine-based nutraceutical, in aiding blood sugar regulation and metabolism in 80 participants over 24 weeks.
Primary Outcome
Evaluation of the effect of Diaberine on blood sugar regulation as measured by changes in HbA1c
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Diaberine
- DIETARY_SUPPLEMENT Placebo Capsule
Study Locations (1)
California
- Citruslabs - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-10-03 |
| Est. Completion | 2025-05-01 |
| Phase | NA |
What NCT06700915 shows while recruiting
NCT06700915 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Metabolism Disorder appearing as the primary indexed condition, and to 2 interventions - of which Diaberine is the first listed.
NCT06700915 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06700915 about?
NCT06700915 is a clinical study titled "A Clinical Trial to Assess the Efficacy and Tolerance of a Berberine-based Nutraceutical Formula to Aid Blood Sugar Regulation and Metabolism". This randomized, triple-blind, placebo-controlled study will evaluate the efficacy of Diaberine, a berberine-based nutraceutical, in aiding blood sugar regulation and metabolism in 80 participants over 24 weeks.
What is the current status of trial NCT06700915?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-10-03. Estimated completion is 2025-05-01.
What conditions does trial NCT06700915 study?
This clinical trial studies the following conditions: Metabolism Disorder, Nutraceutical.
What interventions are being tested in trial NCT06700915?
The interventions under investigation include: Diaberine (DIETARY_SUPPLEMENT), Placebo Capsule (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06700915?
This trial is sponsored by Ultimate International, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06700915 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolism Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06700915's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI